- Abstract:
-
Gene therapy is a promising emerging therapeutic modality for the treatment of cardiovascular diseases and hereditary diseases that afflict the heart. Hence, there is a need to develop robust cardiac-specific expression modules that allow for stable expression of the gene of interest in cardiomyocytes. We therefore explored a new approach based on a genome-wide bioinformatics strategy that revealed novel cardiac-specific cis-acting regulatory modules (CS-CRMs). These transcriptional modules c...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's version
- Publisher:
- Nature Publishing Group Publisher's website
- Journal:
- Molecular Therapy Journal website
- Volume:
- 23
- Issue:
- 1
- Pages:
- 43-52
- Publication date:
- 2014-10-07
- DOI:
- EISSN:
-
1525-0024
- ISSN:
-
1525-0016
- URN:
-
uuid:5a3327aa-ff31-4a9b-9e75-0e51b35e5c4d
- Source identifiers:
-
565481
- Local pid:
- pubs:565481
- Language:
- English
- Keywords:
- Copyright holder:
- The American Society of Gene and Cell Therapy
- Copyright date:
- 2014
- Notes:
- © The American Society of Gene and Cell Therapy. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. This is the publisher's version of the article. The final version is available online from Nature Publishing Group at: [10.1038/mt.2014.178]
Journal article
Genome-wide computational analysis reveals cardiomyocyte-specific transcriptional Cis-regulatory motifs that enable efficient cardiac gene therapy.
Actions
Authors
Funding
Geconcerteerde Onderzoeksactie
More from this funder
Expand funders...
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record